Author

H. Vellama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Salumets· 1 shared D. Lavogina· 1 shared H. Lust· 1 shared J. Jaal· 1 shared K.-L. Eskla· 1 shared M. K. Krolov· 1 shared V. Di Nisio· 1 shared V. Modhukur· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Salumets

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines: onametostat reduces proliferation and viability in both normoxic and hypoxic conditions

D. Lavogina, M. K. Krolov, H. Vellama, V. Modhukur, V. Di Nisio, H. Lust, K.-L. Eskla, A. Salumets, J. Jaal

This study evaluates the efficacy of onametostat, a PRMT5 inhibitor, in reducing glioblastoma cell proliferation and viability under normoxic and hypoxic conditions.

bioRxiv · Oct 28, 2023 · PreprintCancer Biology